Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRestructuring CostsRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Orthopediatrics (KIDS) Operating Expenses (2016 - 2025)

Orthopediatrics (KIDS) has disclosed Operating Expenses for 10 consecutive years, with $53.3 million as the latest value for Q4 2025.

  • On a quarterly basis, Operating Expenses rose 7.37% to $53.3 million in Q4 2025 year-over-year; TTM through Dec 2025 was $211.9 million, a 15.41% increase, with the full-year FY2025 number at $211.9 million, up 15.41% from a year prior.
  • Operating Expenses was $53.3 million for Q4 2025 at Orthopediatrics, down from $54.7 million in the prior quarter.
  • In the past five years, Operating Expenses ranged from a high of $54.7 million in Q3 2025 to a low of $22.2 million in Q3 2021.
  • A 5-year average of $37.0 million and a median of $35.1 million in 2023 define the central range for Operating Expenses.
  • Peak YoY movement for Operating Expenses: dropped 15.14% in 2021, then skyrocketed 47.99% in 2022.
  • Orthopediatrics' Operating Expenses stood at $23.6 million in 2021, then rose by 24.92% to $29.5 million in 2022, then grew by 17.77% to $34.8 million in 2023, then soared by 42.67% to $49.6 million in 2024, then increased by 7.37% to $53.3 million in 2025.
  • Per Business Quant, the three most recent readings for KIDS's Operating Expenses are $53.3 million (Q4 2025), $54.7 million (Q3 2025), and $54.7 million (Q2 2025).